Beijing SL Pharmaceutical – Startup Investor Profile

General Info

Beijing SL Pharmaceutical manufactures and markets genetic engineering drugs, biological drugs, chemical drugs, and medicine preparations.
Location: Haidian
Country:
Industries:
Investment Regions: SEA
Investment Stages: late-stage, pre-seed, seed, series-a


SEA

Want to start building warm intros with this investor?

Get Started for Free

🤖 AI Activity Report

Status: not-active

AI Reasoning: Website and news show company product approvals and company activity but no recent investment/portfolio or startup funding announcements. The latest company news related to investments or equity transactions on the site dates to 2020 (investment in Changfeng/longFeng? ‘长风药业’ F round in 2020). No evidence of any investment in last 12 months. The last known investment-related event found: 长风药业 F round dated 2020-07-02, which is more than 12 months ago; therefore tag: not-active.

Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.

Warm Intros from Portfolio Companies


Founder

Founder

Founder

Founder

Investment Regions Map

loading map…

Similar Investors

Region match

AEI Capital Group

Based on Region
Stage match

Ivy Capital

Based on Stage
Vertical match

Charnez Jacobs

Based on Industry
Other similar investors:



Access all contact details of Beijing SL Pharmaceutical

Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.

Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.

Trusted by Founders like You

Find your matching investors using AI

Sign up to EasyVC